Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a...
Coya Therapeutics’ $26.5 Million Private Placement
ZMC’s Acquisition of InProduction
Willkie Farr & Gallagher LLP acted as legal advisor to InProduction, Lowenstein Sandler LLP acted as legal advisor to ZMC, while Latham & Watkins LLP represented...
Phreesia’s Acquisition of Access eForms
Lowenstein Sandler represented Phreesia in the transaction. Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, announced the acquisition of Access eForms, an...